Clinical and «Clip on» thinking at different training stages according to «General practice – family medicine» specialty.

There was carried out an anonymous questioning– a survey of 6th-year students who received an internship assignment in the specialty «General Practice – Family Medicine», interns and students doing courses in the same specialty in order to diagnose the pre­sence of «clip-on» thinking. M.B. Litvinova test method which is characterized by criterial and categorical validity and corresponds to reliability criterion was used. «Clip on» thinking was diagnosed in 36.5% of the surveyed students on training a budgetary basis and 37.8% of students studying on a contract basis, plus 38.5% of them were at risk. At the stage of postgraduate education (internship training), the percentage of «screen people» (with «clip» type of thinking) was significantly lower, but at the same time the share of the risk group on formation of a «clip» type of thinking was increased. The predominant increase in «people of the book» («long» thinking) among physicians with a certain length of service mainly is due to their age characteristics. Modern medical postgraduate education requires the formation of a qualitatively new approach to the educational process, based on the formation and development of clinical thinking, taking into account psychological characteristics of the modern youth and older colleagues. This phenomenon requires detailed social, andragogical and medical research, the creation of new educational technologies based on «live» communication

The role of out-of-class work of doctor-interns in improving qualitive academic progress on clinical immunology and allergology under the primary specialization “Internal diseases”.

The use of independent out-of-class work of interns on the specialty "Internal diseases" in the section of clinical immunology and allergology promoted the improvement of the qualitative success of interns

Study of effectiveness of antiviral drugs (umifenovir, triazavirin) against acute respiratory viral infections

Aim. Comparative study of clinical efficacy and safety of antiviral drug triazavirin and umifenovir in the treatment of patients with acute respiratory viral infections and influenza. Methods. The study included 100 patients aged 18 to 65 years diagnosed with moderate acute respiratory viral infection. Group 1 included 34 patients receiving umifenovir 200 mg 4 times a day for 5 days, and comparison group included 32 patients who received triazavirin 1 capsule (250 mg) 3 times a day for 5 days. Group 3 (control group) included 34 patients not treated with antiviral therapy. Efficacy and safety of the studied antiviral drugs were evaluated based on clinical symptoms in the disease course and were confirmed by adaptive reactions of the organism. Results. Among patients receiving triazavirin, recovery time and fever, headache and catarrhal syndrome resolution time were less than among patients who received umifenovir. On triazavirin treatment with favorable tolerability, symptomatic medications (antipyretics) were discontinued, and the duration of their use was less, than in patients receiving umifenovir. Evaluation of clinical efficacy of umifenovir and triazavirin for the treatment of acute respiratory viral infections and influenza demonstrated that the drugs effectively reverse the main symptoms of the disease (p <0.05), reduce complications incidence (18.1±2.1% vs. 55.9±3.2%, p <0.05) and contribute to the stabilization of adaptive reactions of the organism in contrast to the results of patients not receiving etiotropic therapy (6.9±2.9% vs. 12.8±2.7, p <0.05). During the use of umifenovir by day 4 and during the use of triazavirin by day 3 intoxication and catarrhal syndromes had been reversed, while in case of the absence of antiviral therapy, 55.8% of patients had continuing intoxication and catarrhal symptoms. Conclusion. The results of the study allow defining umifenovir and triazavirin as the first line of defense against acute respiratory viral infections with good efficacy and tolerability of the drugs